Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SciClone Pharmaceuticals Inc (NASDAQ:SCLN)

13.09
Delayed Data
As of Jun 24
 -0.34 / -2.53%
Today’s Change
6.47
Today|||52-Week Range
15.03
+42.28%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues156.3M127.1M134.8M157.3M
 
 
 
 
 
Cost of Goods Sold22.0M17.7M23.0M21.4M
 
 
 
 
 
Depreciation And Amortization3.4M860.0K852.0K931.0K
 
 
 
 
 
 
Operating ExpensesGross Income130.8M108.5M110.9M134.9M
 
 
 
 
 
General Expenses92.2M94.9M85.0M94.2M
 
 
 
 
 
Other Operating Expenses3.8M0.000.000.00
 
 
Research And Development4.3M6.6M13.7M12.3M
 
 
 
 
 
Total Operating Expenses121.5M113.4M108.8M116.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income34.8M13.6M26.0M40.7M
 
 
 
 
 
Extraordinary Credit15.4M600.0K0.000.00
 
 
 
Extraordinary Charge-43.8M-1.2M---10.8M
 
 
 
 
Interest Expense On Debt185.0K103.0K--0.00
 
 
 
Other Expenses-42.0K195.0K232.0K-510.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income6.3M13.2M26.4M30.3M
 
 
 
 
 
Income Taxes-3.3M-2.2M-1.2M-807.0K
 
 
 
 
 
Net Income9.6M11.0M25.2M29.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS56.6M53.6M51.3M49.8M
 
 
 
 
 
Shares To Calculate EPS Diluted58.5M54.9M52.7M52.2M
 
 
 
 
 
 
Earnings Per ShareEPS$0.16$0.20$0.48$0.56
 
 
 
 
 
EPS Diluted$0.16$0.20$0.48$0.56